ArticleInternational journal for equity in health2026
Social determinants of intersectional inequalities in multimorbidity and its burden in China: a multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA).
Article in International journal for equity in health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundConventional epidemiological studies often rely on average associations for single social determinants, which may obscure heterogeneity across jointly defined social positions. This study applied an intersectionality-informed Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) approach to examine disparities in multimorbidity prevalence and burden among Chinese adults.
methodsWe analyzed 25,409 participants from the 2023-2024 China National Health Survey. Intersectional strata were defined a priori by six social-position dimensions: age, sex, region, residence, educational attainment, and occupational status, yielding 127 observed strata. Multimorbidity was defined as having two or more of 14 chronic conditions, and burden was assessed using the Chinese Multimorbidity Weighted Index (CMWI). MAIHDA models were fitted separately for multimorbidity and CMWI to estimate stratum-specific predictions, variance partition coefficients (VPCs), proportional changes in variance (PCVs), and discriminatory accuracy. Sensitivity analyses examined age restriction, outcome definition, survey-site clustering, lifestyle adjustment, and birthplace-based residence classification.
resultsOverall, multimorbidity prevalence was 22.96%, and mean CMWI was 1.32. Predicted multimorbidity prevalence ranged from 3.36% to 53.37%, and predicted CMWI ranged from 0.19 to 2.95. Higher predicted values were concentrated among older adults, northern residents, participants with lower education, and those who were farmers, unemployed, or retired. Intersectional strata accounted for 16.92% of total variation in multimorbidity and 13.74% in CMWI; discriminatory accuracy for multimorbidity was moderate (AUC = 0.75). Age explained the largest share of between-stratum variance, followed by occupational status and region. Additive main effects explained most between-stratum heterogeneity (PCVs: 82.69% for multimorbidity and 88.37% for CMWI), although residual stratum-specific deviations persisted in a subset of strata. Sensitivity analyses supported the robustness of the findings.
conclusionsMultimorbidity prevalence and burden were unevenly distributed across intersectionally defined social positions in China. Most heterogeneity reflected additive social-position gradients, particularly age, occupation, and region, with smaller residual deviations beyond additivity. These findings support proportionate universalism: universal chronic disease prevention and management should be strengthened, with additional support directed toward socially and regionally disadvantaged groups with greater burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.